Creatd, Inc. (Nasdaq CM: CRTD) (“Creatd” or the “Company”), today announced that, after testing the waters for its proposed Rights Offering, it has elected not to proceed with the offering at this time.
Why Seres Therapeutics Shares Are Popping Off Today
Seres Therapeutics Inc (NASDAQ: MCRB) shares are trading higher by 13.24% to $6.12 Wednesday morning after the company announced it completed the rolling submission process for its BLA to the FDA for SER-109 for recurrent C. difficile infection.
